Other antibodies, including anti-aminoacyl-tRNA synthase antibodies, anti-transcription intermediary factor 1γ (TIF1-γ), anti-nuclear matrix protein 2 (NXP2), and anti-small ubiquitin-like modifier activating enzyme (SAE), are all associated with different presenting symptoms of CADM [6]. The gene discussed is MORC3; the disease is clinically amyopathic dermatomyositis.